There is an increased demand for serology testing for SARS-CoV-2 to identify people who have been exposed to the virus and who may have developed an immune response. However, there are questions about which viral protein to use as an antigen for serology testing. Based on the information we have, the the receptor-binding domain to viral spike protein is perceived as the obvious candidate.1
A coronavirus contains four structural proteins, including spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins.
The coronavirus gets its name from the spike like protrusions that look like a crown. These viruses use the spike protein to bind to proteins on the host cell to gain entry. In the case of SARS-CoV-2, the spike proteins bind angiotensin-converting enzyme 2 (ACE2 receptor) on human cells with high affinity.2
The Value of the Spike Protein
Though the coronavirus uses many different proteins to replicate and invade cells, the spike protein is the major surface protein that it uses to bind to a receptor. After the spike protein binds to the human cell receptor, the viral membrane fuses with the human cell membrane, allowing the genome of the virus to enter human cells and begin infection.3
Studies have also shown that the S protein plays the most important roles in viral attachment, fusion and entry, and it serves as a target for development of antibodies, entry inhibitors and vaccines.4–10
The coronavirus spike protein mediates entry into host cells by attaching to a receptor on respiratory cells called angiotensin-converting enzyme 2, or ACE2,11 .